DDMAC responses to queries posed by drug sponsors or manufacturers regarding ad/promo issues may only be regarded as official (for legal purposes) if they are received in letter form, the division’s director, Thomas Abrams says. He told a Drug Information Association questioner that emails have dominated industry communications, but can’t be relied upon.
From the August 01, 2008 Issue of MM+M - Medical Marketing and Media
